z-logo
Premium
Preparation, Optimization and Characterization of Bovine Lactoferrin‐loaded Liposomes and Solid Lipid Particles Modified by Hydrophilic Polymers Using Factorial Design
Author(s) -
Yao Xudong,
Bunt Craig,
Cornish Jillian,
Quek SiewYoung,
Wen Jingyuan
Publication year - 2014
Publication title -
chemical biology and drug design
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 77
eISSN - 1747-0285
pISSN - 1747-0277
DOI - 10.1111/cbdd.12269
Subject(s) - differential scanning calorimetry , chitosan , liposome , chromatography , bioavailability , polymer , fourier transform infrared spectroscopy , particle size , pectin , controlled release , materials science , chemistry , chemical engineering , organic chemistry , biochemistry , nanotechnology , biology , physics , engineering , thermodynamics , bioinformatics
Bioadhesive liposomes and solid lipid particles (SLPs) modified by pectin and chitosan for oral administration of bovine lactoferrin ( bL f) were prepared using a 2 4 full‐factorial design to identify the key formulation variables influencing particle size and drug entrapment efficiency (EE). Netlike structures of the polymer–particle mixture consisting of a polymeric network in which multiple particles were imbedded were observed by scanning electron microscopy (SEM). Chemical stability of bL f after encapsulation into pectin‐ and chitosan‐modified liposomes and SLPs was confirmed by Fourier transform infrared spectra (FTIR). Bovine lactoferrin was located within phospholipid bilayer, whereas in SLPs bL f was within the matrix. The crystalline nature of bL f after encapsulation was investigated by differential scanning calorimetry (DSC) of drug‐loaded particles, indicating amorphous dispersion of bL f in the polymer–lipid matrix of pectin‐ and chitosan‐modified liposomes and SLPs. In vivo pharmacokinetic investigation of bL f in pectin‐ and chitosan‐modified liposomes and SLPs showed prolonged mean residence time (MRT) of bL f in rat blood and increased the relative bioavailability (F bio %) by 1.95‐ to 2.69‐fold compared with free bL f. The developed carrier systems are considered to be promising vehicles for oral delivery.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here